Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/42716| Title: | Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990 | Authors: | STANDAERT, Baudouin | Issue Date: | 2023 | Publisher: | MDPI | Source: | Vaccines, 11 (11) (Art N° 1646) | Abstract: | Presently, there are at least five important vaccine producers that have already launched or intend to launch a new vaccine designed to prevent infections caused by the Respiratory Syncytial Virus (RSV), which is highly prevalent in the youngest as well as the oldest age groups [...]. | Notes: | Standaert, B (corresponding author), Univ Hasselt, Fac Med & Life Sci, Dept Care & Eth, B-3590 Diepenbeek, Belgium.; Standaert, B (corresponding author), HEBO Bv, B-2020 Antwerp, Belgium. baudouin.standaert@uhasselt.be |
Document URI: | http://hdl.handle.net/1942/42716 | e-ISSN: | 2076-393X | DOI: | 10.3390/vaccines11111646 | ISI #: | WOS:001166851400001 | Rights: | 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory w11, 990.pdf | Published version | 547.61 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.